FRANKLIN LAKES, NJ – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that Laura Boros has been named president of Pharmaceutical Systems (PS), effective today.

Boros will be responsible for driving global strategic, operational and commercial performance of the PS business unit and will report to Mike Garrison, executive vice president (EVP) and president of the Medical segment. Boros succeeds Eric Borin, who was named to president of Medication Delivery Solutions (MDS) in late 2022. Since 2020, Boros has served as senior vice president of global nutrition at Reckitt, a leader in hygiene, health and nutrition brands. 

“Laura has more than 25 years of progressive leadership experience and is uniquely suited to lead PS, one of BD’s highest growth businesses,” said Garrison. “Her global experience, coupled with her track record of driving innovation across the healthcare and consumer industries, will support the next generation of PS growth as it continues to enhance the delivery of medications for the pharmaceutical industry and patients around the world.”

Boros started her career at Procter & Gamble in various country, regional and global roles before joining Hertz as regional vice president for Europe. She then held leadership positions within the pharmaceutical industry at both Novartis and GlaxoSmithKline in high-growth categories. Most recently, she led the global nutrition business at Reckitt and oversaw several strategic M&A projects for the company. She holds a Master of Electrical Engineering degree from Politehnica University in Bucharest, Romania and a Master of Business Administration from Emory Business School in Atlanta, Georgia.